Figure 3 | Scientific Reports

Figure 3

From: Estimating dose-specific cell division and apoptosis rates from chemo-sensitivity experiments

Figure 3

Posterior estimations of Kendall Process means (dose-response curves, left panel), birth rates (middle panel) and death rates (right panel) of cell line BT474 treated with compound Imatinib (a) and cell line HCC1806 treated with compound Cetuximab (b). Curves and shades represent the posterior mean and the 95% credible interval of the corresponding variables, respectively.